Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India flag India · Delayed Price · Currency is INR
1,788.00
+107.80 (6.42%)
Jul 31, 2026, 3:29 PM IST

Tatva Chintan Pharma Chem Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Tatva Chintan Pharma Chem stock has a consensus rating of "Hold" and an average price target of ₹1,443. The average 1-year stock price forecast is 19.32% lower than the current stock price, while the lowest is ₹835.00 (-53.30%) and the highest is ₹1,955 (+9.34%).

Price Target: ₹1,443 (-19.32%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price₹835.00₹1,443₹1,490₹1,955
Change-53.30%-19.32%-16.67%+9.34%

Analyst Ratings

The average analyst rating for Tatva Chintan Pharma Chem stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingOct '25Nov '25Jan '26Apr '26May '26Jul '26
Strong Buy111112
Buy000000
Hold000000
Sell011111
Strong Sell211111
Total333334

Financial Forecast

Revenue This Year
6.39B
from 5.06B
Increased by 26.33%
Revenue Next Year
7.67B
from 6.39B
Increased by 19.99%
EPS This Year
30.20
from 17.98
Increased by 67.96%
EPS Next Year
40.87
from 30.20
Increased by 35.32%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
4.34B4.24B3.94B3.83B5.06B6.39B
Revenue Growth
44.38%-2.31%-7.11%-2.74%32.18%26.33%
Gross Profit
2.32B1.91B2.11B1.77B2.81B3.53B
Gross Margin
53.53%45.08%53.49%46.18%55.61%55.30%
Operating Income
1.00B584.69M437.83M66.82M563.11M993.00M
Net Income
958.74M454.87M303.54M57.13M420.54M712.50M
EPS
----17.9830.20
EPS Growth
----636.89%67.96%
Forward PE
42.2936.0729.9441.0640.1159.21
Dividend / Share
2.002.002.001.002.003.15
Dividend Growth
----50.00%100.00%57.50%
Free Cash Flow
-2.04B-529.30M-672.26M-526.95M-925.59M-342.00M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High6.4B
Avg6.4B
Low6.4B

Revenue Growth

Revenue Growth202720282029
High
26.5%
Avg
26.3%
Low
26.1%

EPS Forecast

EPS202720282029
High31.00
Avg30.20
Low29.40

EPS Growth

EPS Growth202720282029
High
72.4%
Avg
68.0%
Low
63.5%